IAS(r) available on the websitehttps://www.openhealth.fr/ias

Introduction
​

IAS® Poux is used to analyse the incidence of head lice in France on a daily basis. It is particularly well suited to monitoring the spatial and temporal evolution of lice.

Products

For each of the IAS®, these are weighted baskets of medicines and healthcare products dispensed over the counter in pharmacies and pathology markers.

These market definitions have been the subject of research and are regularly reviewed to take account of changes in product scope and practices.

As this is our intellectual property, we cannot provide access to these details.

​Sources
OpenHealth The HUB - PHARMA: consumption data from pharmacies
Drug database source: SIPS THESORIMED
Source WHO ATC Classification: WHO ATC Version 2020

Territory
Metropolitan France - excluding Corsica
Geographical breakdown: French administrative regions as at 01/01/2016

Period
​From 01/07/2014 to date
​
​Market definition
Type: Human medicine according to WHO ATC class code assignments - 2020 version - from the THESORIMED source.

Illustration at 04/01/2023:

Threshold :

Cases per 100,000 inhabitants per day.

National: 98.8

> 200Level 4 - epidemic phase

140 - 200Level 3 - pre (or post) epidemic phase

105 - 140Level 2 - non-alert phase

< 105Level 1 - reference